NIH plans to scale back animal testing in federally funded analysis

Ed Silverman, a senior author and Pharmalot columnist at STAT, has been protecting the pharmaceutical trade for practically three many years.

In a big transfer, the U.S. Nationwide Institutes for Well being stated it might cut back its reliance on animals in federally funded analysis and as an alternative prioritize funding in human-based alternate options, the second time this month {that a} key authorities company has taken such a step.

To realize its aim, the NIH plans to determine a brand new workplace for overseeing progressive analysis and coordinating agency-wide efforts to “develop, validate and scale” using “non-animal approaches” to biomedical analysis. The brand new workplace can even increase funding and coaching with a watch towards assessing appropriate analysis strategies and make them extra accessible to researchers.

“For many years, our biomedical analysis system has relied closely on animal fashions. With this initiative, NIH is ushering in a brand new period of innovation,” Director Jay Bhattacharya stated in an announcement.